Provisional Consent to the Distribution of a New Medicine Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisional consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Nelfinavir mesylate 292.25 mg equivalent to 250 mg nelfinavir Tablet Mova Pharmaceutical Corporation, Caguas, Puerto Rico Viracept Nelfinavir mesylate 58.5 mg/g equivalent to 50 mg/g nelfinavir in 144 g Powder, oral Mova Pharmaceutical Corporation, Caguas, Puerto Rico Viracept Note: This consent is valid for 2 years from the date of publication of this notice. Dated this 30th day of January 1998. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.